We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In brief.
- Abstract
The article offers news briefs related to health care industry in the U.S. Abbott Laboratories Inc. will sell its AIDS drug Kaletra for a reduced price in Brazil, lifting the threat that the country may license it mandatorily. A 2,000-page intellectual property (IP) guidebook has been compiled as a resource for public health and agriculture specialists. ULive PLC has withdrawn its plans for an initial public share offering on London's Alternative Investment Market (AIM).
- Subjects
UNITED States; SELLING of drugs; ABBOTT Laboratories Inc.; INTELLECTUAL property; REFERENCE sources; ULIVE PLC; GOING public (Securities); HEALTH care industry
- Publication
Nature, 2007, Vol 448, Issue 7150, p121
- ISSN
0028-0836
- Publication type
Article
- DOI
10.1038/448121a